Product Information| Package | Brand | Formulation | Pack Size | Indications | Generic Strength |
|---|---|---|---|---|---|
|
Bett Injection | Injection | 0.5 ml | Tetanus | 0.5 ml contains Tetanus Toxoid > 5Lf to <25 Lf |
|
BEVAC 0.5 ML | Vaccine | 0.5ml Vial | -- | Each 0.5 ml contains: Purified HBsAg – 10mcg, Aluminium Hydroxide gel – 0.25mg, Thiomersal I.P. – 0.025mg |
|
BEVAC 1 ML | Vaccine | 1ml Vial | -- | Each 1 ml contains: Purified HBsAg – 20mcg, Aluminium Hydroxide gel – 0.5mg, Thiomersal I.P. – 0.05mg |
|
BEVAC 10 ML | Vaccine | 10ml Vial | -- | Each 1 ml contains: Purified HBsAg – 20mcg, Aluminium Hydroxide gel – 0.5mg, Thiomersal I.P. – 0.05mg |
|
BE Td 0.5 ML | Vaccine | 0.5 ml Amp. | -- | Each dose of 0.5 ml contains: Diphtheria Toxoid ≤ 2 Lf Tetanus Toxoid ≥ 5 Lf to ≤ 25 Lf Adsorbed on Aluminium Phosphate (as AIPO4) ≥ 1.5 mg Thiomersal I.P. 0.01% w/v |
|
BE Td 5 ML | Vaccine | 5 ml Vial | -- | Each dose of 0.5 ml contains: Diphtheria Toxoid ≤ 2 Lf Tetanus Toxoid ≥ 5 Lf to ≤ 25 Lf Adsorbed on Aluminium Phosphate (as AIPO4) ≥ 1.5mg Thiomersal I.P. 0.01% w/v |
|
BERAB 0.5 ML | Vaccine | 0.5ml Vial | -- | (Puried Vero Cell Rabies Vaccine) Label Composition : Puried Lyophilized Rabies antigen derived from Rabies Virus (L. Pasteur 2061/Vero strain propagated in Vero cells), Inactivated. S Potency .≥2.5 IU per vial, Stabilizers :Maltose and Human Albumin: q.s. S Preservative: Thiomersal ≤0.015% w/v Reconstituted with 0.5ml diluent (0.9% w/v Sodium Chloride Inj. IP) |
|
ComBE Five 0.5 ML | Vaccine | 0.5 ml Vial | -- | Each reconstituted dose of 0.5ml Diphtheria Toxoid- ≥ 20 Lf to ≤30 Lf Tetanus Toxoid =>5Lf to ≤ 25 Lf B. Pertussis (Whole Cell) ≥ 4 IU r-HbsAg - ≥ 10 mcg Purified Capsular Polysaccharide (PRP) – 10 mcg Tetanus Toxoid (Carrier protein) – 19 to 33mcg Aluminium Hydroxide gel – 0.25mg Thiomersal I.P. 0.01% w/v |
|
ComBE Five 0.5 ML | Vaccine | 0.5 ml PFS | -- | Each reconstituted dose of 0.5 ml Diphtheria Toxoid- ≥ 20 Lf to ≤30 Lf Tetanus Toxoid =>5Lf to ≤ 25 Lf B. Pertussis (Whole Cell) ≥ 4 IU r-HbsAg - ≥ 10mcg Purified Capsular Polysaccharide (PRP) – 10 mcg Tetanus Toxoid (Carrier protein) – 19 to 33mcg Aluminium Hydroxide gel – 0.25mg Thiomersal I.P. 0.01% w/v |
|
JEEV 3mcg, 0.5 ML | Vaccine | 0.5ml Vial | -- | Inactivated Vero Cell Japanese Encephalitis Vaccine |
|
JEEV 6mcg, 0.5 ML | Vaccine | 0.5ml Vial | -- | Inactivated Vero Cell Japanese Encephalitis Vaccine |
|
JEEV 3mcg, 0.5 ML | Vaccine | 0.5 PFS | -- | Inactivated Vero Cell Japanese Encephalitis Vaccine |
|
JEEV 6mcg, 0.5 ML | Vaccine | 0.5ml PFS | -- | Inactivated Vero Cell Japanese Encephalitis Vaccine |
|
HAPIBEV , 0.5 ML | Vaccine | 0.5ml PFS | -- | Inactivated Hepatitis A Vaccine (Adsorbed) I.P. Inactivated HAV Antigen (TZ84 strain) 250u Aluminium (as aluminium Hydroxide) 0.175 ~ 0.31 mg Disodium Hydrogen Phosphate-q.s. Sodium chloride- 4.5 mg Sodium Dihydrogen Phosphate - q.s. Water for injection - q.s. to 2.5mL Produced in Human Diploid (2BS) Cells |
|
Bett Injection | Injection | 0.5 ml | Injection | 0.5 ml contains Tetanus Toxoid > 5Lf to <25 Lf |
|
PNEUBEVAX 14 | Vaccine | 0.5 mL Vial | Vaccine | Each dose of 0.5 mL contains: Pneumococcal polysaccharide serotype 1….3.0 μg Pneumococcal polysaccharide serotypes 3, 4, 5, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F… 2.2 μg Pneumococcal polysaccharide serotype 6B…4.4 μg Adsorbed onto Aluminum Phosphate, as Al+++…≤ 0.75 mg Polysaccharide conjugated to…20 – 50 µg of CRM197 Other ingredients: Polysorbate 20, Succinic Acid |
Disclaimer: This website contains the details of products which are marketed by Biological E in Indian Pharma Market. To know about the entire product portfolio of Biological E, please visit our corporate website. *Details of the products given here are for the information of registered medical practitioners only. If you are not a registered medical practitioner, please be cautioned that these products are not supposed to be used without an advice from a registered medical practitioner.
